Clinical trial
Improve Management of Heart Failure With Procalcitonin - Biomarkers in Cardiology 18
NCT02392689 is registered in ClinicalTrials.gov with Brahms AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improve Management of Heart Failure With Procalcitonin - Biomarkers in Cardiology 18
- Lead sponsor
- Brahms AG
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 31, 2015
- Completion date
- April 14, 2018
- Enrollment
- 759 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, infection